Wave Life Sciences, Inc. (WVE)
NASDAQ: WVE · Real-Time Price · USD
5.04
-0.12 (-2.33%)
At close: Aug 28, 2026, 4:00 PM EDT
5.09
+0.05 (1.07%)
After-hours: Aug 28, 2026, 7:59 PM EDT
Wave Life Sciences Market Cap
Wave Life Sciences has a market cap or net worth of $993.12 million as of August 28, 2026. Its market cap has decreased by -38.12% in one year.
Market Cap
993.12M
Enterprise Value
546.11M
1-Year Change
-38.12%
Ranking
Category
Stock Price
$5.04
ChartMarket Cap Chart
Since November 11, 2015, Wave Life Sciences's market cap has increased from $334.93M to $993.12M, an increase of 196.51%. That is a compound annual growth rate of 10.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 993.12M | -68.08% |
| Dec 31, 2025 | 3.11B | 64.89% |
| Dec 31, 2024 | 1.89B | 213.58% |
| Dec 29, 2023 | 601.65M | -1.10% |
| Dec 30, 2022 | 608.37M | 229.32% |
| Dec 31, 2021 | 184.73M | -51.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 1.10B |
| Avalo Therapeutics | 1.05B |
| Solid Biosciences | 1.05B |
| Lexicon Pharmaceuticals | 1.02B |
| Arbutus Biopharma | 1.00B |
| Candel Therapeutics | 1.00B |
| Immix Biopharma | 997.26M |
| Geron | 970.13M |